Nancy Duarte-Lonnroth
Plus aucun poste en cours
Historique de carrière de Nancy Duarte-Lonnroth
Anciens postes connus de Nancy Duarte-Lonnroth
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACER THERAPEUTICS INC. | Corporate Officer/Principal | 01/05/2018 | - |
| CELESTICA INC. | Conseiller Juridique Général | 04/02/2010 | - |
| Corporate Officer/Principal | 18/03/2013 | 20/03/2013 |
Formation de Nancy Duarte-Lonnroth
| University of Massachusetts | Graduate Degree |
| Franklin Pierce University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Electronic Technology | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CELESTICA INC. | Electronic Technology |
| Entreprise privées | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Bourse
- Insiders
- Nancy Duarte-Lonnroth
- Expérience
